BioELife Corp Mobilizes to Produce and Distribute Coronavirus (COVID-19) and Bacteria Protection Products

Author's Avatar
Mar 12, 2020
Article's Main Image

HENDERSON, Nev., March 12, 2020 (GLOBE NEWSWIRE) -- BioELife Corp. (OTC QB: LITH) (the “Company”), formerly known as US Lithium Corp., announces that the Company’s chemists and medical advisors have completed their specifications for, and selection of, virus and bacteria protection products including a powerful hand sanitizer fortified with CBD and ultra-protective Nano-Fiber Face Masks. The masks will be manufactured by Respilon, a leading producer of nanofiber products. These products will be part of the Company’s BioEDefender product line and are now available for pre-order on the Company’s ecommerce site, www.bioelife.net, with expected fulfillment the first week of April.

The core of the masks consists of the latest technology using four layers of protection including a nanofiber membrane, RespiPro, with a 60 nano-meter opening that mechanically captures 99.9% of viruses and bacteria. These masks also contain a revolutionary layer of fabric with accelerated copper dioxide (ACuO) which deactivates viruses and bacteria with a 99.9% efficiency. This new pathogen-deactivating feature helps reduce the spread of viruses. The masks can be reused for several days and are not considered biohazardous material after use. A second version, the Respiratory Shield, also has a Bacterial and Virus Filtration Efficiency of 99.9% and with same benefits but was engineered for 50 washing cycles. See more including videos at www.respimasks.com.

The BioEDefense Hand Sanitizer is a proprietary formulation that combines Vitamin E, Aloe, and other nutrients fortified with pure CBD in a blend with a 70% alcohol base. This exceeds the Center for Disease Control’s recommended alcohol potency for viral and bacterial defense and protection. While CBD is not a cure for the Coronavirus, its anti-bacteria, anti-anxiety, anti-inflammatory properties can assist and be very beneficial in the fight against this global pandemic.

Gregory Rotelli, Chairman of the Board and President of BioELife stated, “We are very proud of our emerging virus and bacteria protection product line which was specifically designed to aid this worldwide crisis. Our Respilon masks are by far the most effective available due to their revolutionary Nano-Fiber Technology and our BioEDefense Sanitizer exceeds The Center for Disease Control (CDC) Guidelines for viral and bacterial defense while being fortified with the beneficial proprieties of CBD. Most importantly, we are providing these critically important products on our ecommerce site, www.bioelife.net, at an attractive value point compared to less effective options being sold by our competitors at much higher price points.”

About the Company

BioELife Corp. was created by successful pharmaceutical entrepreneurs dedicated to using nature’s resources to fight pain and infection while reducing the dependency on opioids and their terrible side effects. The Company is uniquely positioned to capitalize on the emerging Cannabinoid market that is growing at phenomenal rates and is expected to reach $20 Billion over the next five years. The Company has created a ‘seed to shelf’ value-added product development and marketing organization with direct contracts for raw materials, scientific proprietary formulation, manufacturing, and distribution of medically focused Cannabinoid products.

Notice Regarding Forward-Looking Statements

Disclaimer: This press release contains statements, which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of BioELife Corp. and members of their management and Board of Directors as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact:
Gregory C. Rotelli
Chairman and President
www.bioelife.com
1-888-712-1047
[email protected]

ti?nf=Nzg2ODYxNSMzMzk1MDczIzIwMjkxNTE=